Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL Meeting Abstract


Authors: Park, J. H.; Riviere, I.; Wang, X. Y.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203838
PROVIDER: wos
Notes: Meeting Abstract: 7020 -- Source: Wos
MSK Authors
  1. Renier J Brentjens
    189 Brentjens
  2. Jae Hong Park
    132 Park
  3. Michel W J Sadelain
    453 Sadelain
  4. Isabelle C Riviere
    161 Riviere
  5. Xiuyan Wang
    62 Wang
  6. Shirley M Bartido
    34 Bartido